ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
ANIP on Nasdaq
Shares outstanding
22,278,088
Price per share
$84.35
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
21,151,319
Total reported value
$1,669,922,518
% of total 13F portfolios
0%
Share change
+543,953
Value change
+$30,060,706
Number of holders
281
Price from insider filings
$84.35
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 11% $230,596,038 2,517,424 BlackRock, Inc. 30 Sep 2025
Meridian Venture Partners II GP, L.P. 4.8% -12% $66,419,394 -$9,630,000 1,034,570 -13% Robert E. Brown, Jr. 21 Aug 2025
MILLENNIUM MANAGEMENT LLC 3.8% -28% $57,136,569 -$19,037,261 818,341 -25% Millennium Management LLC 31 Mar 2025
INTEGRATED CORE STRATEGIES (US) LLC 0.3% -98% $5,976,442 -$96,309,614 65,245 -94% Millennium Management LLC 30 Sep 2025

As of 31 Dec 2025, 281 institutional investors reported holding 21,151,319 shares of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP). This represents 95% of the company’s total 22,278,088 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 2,661,712 +4.4% 0% $210,115,544
VANGUARD GROUP INC 5.9% 1,305,068 +2.2% 0% $103,022,068
STATE STREET CORP 3.3% 727,204 +2.2% 0% $57,405,484
Global Alpha Capital Management Ltd. 2.6% 590,135 -6.4% 2.8% $46,585,257
MILLENNIUM MANAGEMENT LLC 2.4% 539,665 +727% 0.03% $42,601,155
DIMENSIONAL FUND ADVISORS LP 2.2% 487,667 -3.5% 0.01% $38,497,108
Soleus Capital Management, L.P. 2.2% 486,243 +43% 1.6% $38,384,022
TANG CAPITAL MANAGEMENT LLC 2.2% 481,437 +52% 1.9% $38,004,637
Deep Track Capital, LP 2.1% 477,684 +6.2% 0.86% $37,708,375
GEODE CAPITAL MANAGEMENT, LLC 2.1% 477,272 +4.2% 0% $37,681,704
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 2.1% 473,207 +31% 0.02% $37,354,961
GOLDMAN SACHS GROUP INC 1.8% 400,278 +5.6% 0% $31,597,946
DEUTSCHE BANK AG\ 1.8% 392,576 +55% 0.01% $30,989,950
Nuveen, LLC 1.7% 387,102 -2% 0.01% $30,557,832
Ranger Investment Management, L.P. 1.6% 362,378 +34% 2% $28,606,119
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.4% 316,693 -9.2% 0.07% $24,999,745
RENAISSANCE TECHNOLOGIES LLC 1.4% 314,402 +15% 0.04% $24,818,894
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 1.3% 299,278 0% 0.04% $23,625,000
MORGAN STANLEY 1.3% 281,427 +21% 0% $22,215,920
AMERIPRISE FINANCIAL INC 1.2% 269,903 -7.5% 0% $21,306,143
D. E. Shaw & Co., Inc. 1.1% 253,536 +19% 0.02% $20,014,132
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 251,629 +6.8% 0% $19,863,593
JPMORGAN CHASE & CO 1.1% 244,670 +90% 0% $19,314,250
Aberdeen Group plc 1.1% 240,792 -11% 0.03% $19,008,121
NOMURA HOLDINGS INC 1% 223,935 +15% 0.13% $17,677,429

Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 21,151,319 $1,669,922,518 +$30,060,706 $78.94 281
2025 Q3 20,389,328 $1,867,651,983 +$52,854,102 $91.60 266
2025 Q2 19,725,780 $1,287,090,849 -$20,870,018 $65.25 229
2025 Q1 19,963,692 $1,336,584,283 +$48,405,121 $66.95 226
2024 Q4 19,278,460 $1,065,666,126 +$20,364,527 $55.28 204
2024 Q3 18,878,833 $1,126,182,384 +$220,571,922 $59.66 207
2024 Q2 15,122,528 $963,007,127 +$64,529,569 $63.68 200
2024 Q1 14,090,492 $974,037,268 +$37,316,448 $69.13 195
2023 Q4 13,616,342 $750,788,600 +$15,033,397 $55.14 180
2023 Q3 13,199,659 $766,379,240 +$52,240,515 $58.06 184
2023 Q2 12,299,725 $662,081,429 +$105,431,062 $53.83 169
2023 Q1 10,365,411 $411,702,884 +$7,764,406 $39.72 137
2022 Q4 10,254,354 $412,610,775 +$2,387,720 $40.23 125
2022 Q3 10,269,268 $330,253,290 +$12,871,843 $32.14 115
2022 Q2 9,879,095 $293,397,646 +$29,894,218 $29.67 109
2022 Q1 9,205,000 $258,822,043 -$5,750,270 $28.11 115
2021 Q4 8,972,675 $413,375,358 +$78,226,286 $46.08 126
2021 Q3 7,280,546 $238,830,760 +$14,353,157 $32.82 105
2021 Q2 7,204,407 $252,488,638 -$2,871,513 $35.05 104
2021 Q1 7,293,016 $263,483,493 +$391,549 $36.14 100
2020 Q4 7,361,043 $213,798,867 +$1,986,104 $29.04 109
2020 Q3 7,312,777 $206,302,713 -$6,295,496 $28.21 105
2020 Q2 7,466,801 $241,329,748 -$25,517,337 $32.34 124
2020 Q1 7,973,561 $324,820,687 -$11,764,194 $40.74 135
2019 Q4 8,093,378 $499,022,609 -$70,945,248 $61.67 161
2019 Q3 9,115,689 $664,230,757 +$37,860,037 $72.88 181
2019 Q2 8,576,026 $705,083,478 +$79,655,054 $82.20 190
2019 Q1 7,702,646 $543,125,675 +$45,892,557 $70.54 183
2018 Q4 7,079,477 $318,725,901 -$18,340,193 $45.02 158
2018 Q3 7,500,122 $423,927,111 +$15,362,009 $56.54 164
2018 Q2 7,191,053 $480,388,569 +$39,751,902 $66.80 179
2018 Q1 6,622,638 $385,621,004 +$5,056,635 $58.22 166
2017 Q4 6,543,742 $421,877,087 +$7,855,697 $64.45 152
2017 Q3 6,413,607 $336,579,902 -$1,240,416 $52.49 135
2017 Q2 6,496,859 $305,032,164 +$451,131 $46.80 145
2017 Q1 6,453,052 $319,499,983 +$59,803,632 $49.51 151
2016 Q4 6,252,710 $379,236,629 +$11,513,195 $60.62 151
2016 Q3 6,033,380 $400,349,646 +$29,865,427 $66.35 166
2016 Q2 5,605,143 $312,867,690 +$11,945,824 $55.82 134
2016 Q1 5,798,068 $195,120,743 -$21,503,997 $33.66 115
2015 Q4 6,319,783 $285,412,733 -$31,094,929 $45.12 119
2015 Q3 6,966,028 $275,308,091 +$16,995,961 $39.51 118
2015 Q2 6,494,641 $402,533,646 -$29,199,720 $62.05 120
2015 Q1 6,959,392 $434,650,108 +$84,590,578 $62.55 124
2014 Q4 5,627,718 $317,206,714 +$97,075,054 $56.39 99
2014 Q3 4,525,202 $128,520,656 -$2,966,635 $28.28 69
2014 Q2 4,487,871 $154,563,359 +$28,391,675 $34.44 78
2014 Q1 3,764,373 $118,010,408 +$77,289,139 $31.35 64